Covered recipient · General Payments record
LEONORA BOMAR
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$1,381.84
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $336.72 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Dermavant Sciences, Inc. | $78.85 | 1 |
| Inari Medical, Inc. | $59.86 | 1 |
| ABBVIE INC. | $51.67 | 2 |
| GENZYME CORPORATION | $38.19 | 2 |
| Arcutis Biotherapeutics, Inc. | $32.25 | 2 |
| Janssen Biotech, Inc. | $31.50 | 2 |
| Amgen Inc. | $25.59 | 1 |
| E.R. Squibb & Sons, L.L.C. | $18.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.38 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103345078 | CMS |
| ABBVIE INC. | $26.29 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103345080 | CMS |
| Amgen Inc. | $25.59 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117206205 | CMS |
| Arcutis Biotherapeutics, Inc. | $14.66 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121059919 | CMS |
| Arcutis Biotherapeutics, Inc. | $17.59 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121059917 | CMS |
| Dermavant Sciences, Inc. | $78.85 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127852738 | CMS |
| E.R. Squibb & Sons, L.L.C. | $18.81 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101690593 | CMS |
| GENZYME CORPORATION | $19.65 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139584904 | CMS |
| GENZYME CORPORATION | $18.54 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139584942 | CMS |
| Inari Medical, Inc. | $59.86 | 08/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140064319 | CMS |
| Janssen Biotech, Inc. | $15.40 | 10/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078332832 | CMS |
| Janssen Biotech, Inc. | $16.10 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078333363 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.